These findings support the potential use of urinary EVs as biomarkers of T2DM-related DN and suggest that lower NEDD4L levels within these vesicles may be an indicator of the extent of DN-associated tubular injury. The gene discussed is NEDD4L; the disease is liver dysplastic nodule.